Search research articles
Contact Us
Filters
Showing results (191-200 of 238) with videos related to
Page
of 24
Sort By:
JAMA Oncology
|
November 4, 2021
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study
Caroline A Nebhan, Alessio Cortellini, Weijie Ma, et al.
Cancers
|
July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
David J Pinato, Alvin J X Lee, Federica Biello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 11, 2021
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice
David J Pinato, Thomas U Marron, Pallavi Shruti Mishra-Kalyani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
Somaieh Hedayat, Luciano Cascione, David Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2020
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Journal of Translational Medicine
|
June 25, 2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
Daniele Santini, Tea Zeppola, Marco Russano, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
European Urology Oncology
|
January 11, 2021
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 238) with videos related to
Sort By:
Page
of 24
JAMA Oncology
|
November 4, 2021
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study
Caroline A Nebhan, Alessio Cortellini, Weijie Ma, et al.
Cancers
|
July 12, 2020
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
David J Pinato, Alvin J X Lee, Federica Biello, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 11, 2021
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice
David J Pinato, Thomas U Marron, Pallavi Shruti Mishra-Kalyani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
Somaieh Hedayat, Luciano Cascione, David Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2020
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Journal of Translational Medicine
|
June 25, 2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
Daniele Santini, Tea Zeppola, Marco Russano, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
European Urology Oncology
|
January 11, 2021
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Page
of 24